LABU Holdings Information

LABU is an equity ETF with a total of 161 individual holdings.

Total Holdings

161

Top 10 Percentage

35.65%

Asset Class

Equity

ETF Category

Trading--Leveraged Equity

Assets

491.84M

PE Ratio

n/a

Breakdown by Sector

No.	Symbol	Name	% Weight	Shares
1	n/a	Goldman Sachs Fin Gov 465 Institut	13.83%	74,951,153
2	n/a	Dreyfus Govt Cash Man Ins	6.83%	37,002,729
3	n/a	Goldman Finl Sq Trsry Inst 506	6.04%	32,746,644
4	MRNA	Moderna, Inc.	1.67%	167,921
5	n/a	S&P Biotechnology Select Industry Index Swap	1.38%	25,717
6	ROIV	Roivant Sciences Ltd.	1.26%	240,848
7	ACLX	Arcellx, Inc.	1.23%	58,248
8	PCVX	Vaxcyte, Inc.	1.15%	112,088
9	RVMD	Revolution Medicines, Inc.	1.14%	62,597
10	CGON	CG Oncology, Inc.	1.13%	88,866
11	FOLD	Amicus Therapeutics, Inc.	1.10%	413,180
12	MIRM	Mirum Pharmaceuticals, Inc.	1.09%	61,125
13	GILD	Gilead Sciences, Inc.	1.07%	40,172
14	PRAX	Praxis Precision Medicines, Inc.	1.04%	18,637
15	AMGN	Amgen Inc.	1.03%	15,458
16	CELC	Celcuity Inc.	1.01%	47,868
17	UTHR	United Therapeutics Corporation	1.00%	10,053
18	KRYS	Krystal Biotech, Inc.	0.96%	20,335
19	PTGX	Protagonist Therapeutics, Inc.	0.96%	53,340
20	REGN	Regeneron Pharmaceuticals, Inc.	0.94%	6,710
21	BMRN	BioMarin Pharmaceutical Inc.	0.94%	90,777
22	BIIB	Biogen Inc.	0.94%	27,449
23	VRTX	Vertex Pharmaceuticals Incorporated	0.94%	10,960
24	HALO	Halozyme Therapeutics, Inc.	0.93%	77,805
25	CYTK	Cytokinetics, Incorporated	0.93%	80,875

Showing 25 of 161 holdings

Subscribe to see the full list

As of Mar 17, 2026